Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
MBL Life Sciences


| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | BV421 |
| Immunogen | HPV16 E7 |
| Peptide Sequence | RAHYNIVTF |
| Class | Class I |
| Sequence Location | 49-57 |
| MHC Allele | H-2Db |
| Documents & Links for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 | |
| Datasheet | H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 Datasheet |
| Documents & Links for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 | |
| Datasheet | H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 Datasheet |
| Citations for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 – 1 Found |
| Quayle, Steven N; Girgis, Natasha; Thapa, Dharma R; Merazga, Zohra; Kemp, Melissa M; Histed, Alex; Zhao, Fan; Moreta, Miguel; Ruthardt, Paige; Hulot, Sandrine; Nelson, Alyssa; Kraemer, Lauren D; Beal, Dominic R; Witt, Luke; Ryabin, Jessica; Soriano, Jonathan; Haydock, Mark; Spaulding, Emily; Ross, John F; Kiener, Peter A; Almo, Steven; Chaparro, Rodolfo; Seidel, Ronald; Suri, Anish; Cemerski, Saso; Pienta, Kenneth J; Simcox, Mary Ellen. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2020;26(8):1953-1964. PubMed |

| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | BV421 |
| Immunogen | HPV16 E7 |
| Peptide Sequence | RAHYNIVTF |
| Class | Class I |
| Sequence Location | 49-57 |
| MHC Allele | H-2Db |
| Documents & Links for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 | |
| Datasheet | H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 Datasheet |
| Documents & Links for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 | |
| Datasheet | H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 Datasheet |
| Citations for H-2Db HPV16 E7 Tetramer-RAHYNIVTF-BV421 – 1 Found |
| Quayle, Steven N; Girgis, Natasha; Thapa, Dharma R; Merazga, Zohra; Kemp, Melissa M; Histed, Alex; Zhao, Fan; Moreta, Miguel; Ruthardt, Paige; Hulot, Sandrine; Nelson, Alyssa; Kraemer, Lauren D; Beal, Dominic R; Witt, Luke; Ryabin, Jessica; Soriano, Jonathan; Haydock, Mark; Spaulding, Emily; Ross, John F; Kiener, Peter A; Almo, Steven; Chaparro, Rodolfo; Seidel, Ronald; Suri, Anish; Cemerski, Saso; Pienta, Kenneth J; Simcox, Mary Ellen. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2020;26(8):1953-1964. PubMed |